Compare KALA & FXNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KALA | FXNC |
|---|---|---|
| Founded | 2009 | 1907 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 319.6M | 265.0M |
| IPO Year | 2017 | 2012 |
| Metric | KALA | FXNC |
|---|---|---|
| Price | $0.17 | $28.42 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $31.50 | N/A |
| AVG Volume (30 Days) | ★ 2.7M | 77.9K |
| Earning Date | 04-15-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 2.37% |
| EPS Growth | 67.39 | ★ 96.00 |
| EPS | N/A | ★ 1.96 |
| Revenue | N/A | ★ $7,717,000.00 |
| Revenue This Year | N/A | $12.21 |
| Revenue Next Year | N/A | $2.93 |
| P/E Ratio | ★ N/A | $14.54 |
| Revenue Growth | N/A | ★ 7.40 |
| 52 Week Low | $0.15 | $18.35 |
| 52 Week High | $20.58 | $29.85 |
| Indicator | KALA | FXNC |
|---|---|---|
| Relative Strength Index (RSI) | 34.98 | 54.37 |
| Support Level | $0.15 | $24.22 |
| Resistance Level | $0.24 | $28.89 |
| Average True Range (ATR) | 0.02 | 0.65 |
| MACD | 0.01 | -0.03 |
| Stochastic Oscillator | 15.73 | 42.18 |
Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.
First National Corp is a bank holding company of First Bank, which is a commercial bank. Its core offering includes loans, deposits, wealth management, and other products and services. The Company operates through two reportable operating segments: Community Banking and wealth management. The Community Banking segment involves making loans and generating deposits from individuals, businesses, and charitable organizations. Wealth Management Services offers corporate trustee services, trust and estate administration, IRA administration and custody services. The company has revenue from Community Banking segment.